The carboxy-terminal cross-linking domain (NCI) of type IV procollagen was isolated from human placenta and used for the production of polyclonal and monoclonal antibodies. Purity of the antigen and specificity of the antibodies were verified by Western blotting and radioimmunoassays.
Introduction
Basement membranes (BM)' are extracellular sheetlike structuires that play a major role in cell differentiation and morphogenesis. They serve as flexible mechanical support for endothelial and carboxy-terminal cross-linking domain of type IV procollagen; NEM, N-ethyl maleimide; PIIIP, amino-terminal procollagen type III peptide; RIA, radioimmunoassay. epithelial cells and form a filtration barrier in the kidney glomerulus or between circulatory and interstitial compartments (for reviews, see References 1-3). BM architecture is destroyed or altered in states of inflammation (2) , tumor invasion (4), or hepatic fibrosis (5) . Recently, rapid progress has been made in the isolation and characterization of the major structural components ofall BM (for reviews, see References 6 and 7): laminin, a cross-shaped glycoprotein with a molecular weight of 1,000 kD (8) that mediates cellular attachment to other BM molecules (9) ; heparan sulfate proteoglycan (10) which interacts with a domain of laminin (1 1); nidogen, a recently characterized glycoprotein whose function is yet unknown (12) ; and type IV (BM) collagen which represents the principal scaffold for the other BM structures.
Based on biochemical and electron-microscopic evidence, Timpl et al. (13) postulated a network model for BM collagen, in which four amino-terminal regions of type IV procollagen are linked together to form the 7-S domain (14) and the carboxyterminal globular extensions of two molecules are combined to build the hexameric carboxy-terminal cross-linking (NCI) domaih of type IV procollagen (13, 15) . The isolated NCI globule has recently been investigated more thoroughly by biochemical and electron-microscopic methods (16) .
Sensitive radioimmunoassays have been developed for mouse 7-S collagen (14) and pepsin fragments P1 and P2 of mouse laminin (17) , and sigmificant elevations of cross-reacting antigens in streptozotocin-didbetic rats were detected (18) . The radioimmunoassays described for human 7-S collagen and the laminin P1 fragment (19, 20) either suffer from low sensitivity for measurements in normal human serum or from the nonparallelity of serum inhibition curves, respectively (our own unpublished results). Furthermore, it is not clear whether these circulating antigens reflect noyel synthesis or degradation ofBM structures, or both. In search for sensitive and precise serum parameters of BM metabolism in humans, we focused on fragment NCO, the carboxy-terminal noncollagenous domain of type IV collagen. This collagenase-resistant structure has recently gained widespread attention as the presumptive autoantigen of Goodpasture's syndrome (21) (22) (23) (24) . It was shown by Wieslander et al. (22) that the autoantigenic epitope is buried in the globular structure and only exposed upon denaturation (25) .
In this report, we describe a sensitive radioimmuiloassay for human NC1 and present the first analysis ofthe antigen in serum and other biological fluids under normal and abnormal conditions.
Methods
Purification offragment NCI. Human placenta was collected in 100 mM Tris, 4 N NaCI, pH 7.4, with 5 mM N-ethylmaleimide (NEM), 2 mM phenylmethylsulfonyl fluoride, and 20 mM ethylene diaminetetraacetate (Na2-EDTA) added to inhibit protease activity. After homogenization, the tissue was washed with 3 liters of 20 mM Na2-EDTA, 1% Triton X-100, pH 7.4, per kilogram of wet weight, then washed extensively with distilled water, and finally preextracted with 5 liters of cold 0.5 N acetic acid. 1 kg of preextracted homogenate was suspended in 2 liters of 50 mM Tris, 5 mM CaCl2, 2 mM NEM, pH 7.6, and digested with crude collagenase (Boehringer, Mannheim, Federal Republic of Germany, 5 mg/kg wet weight) for 40 h at 20°C. The supernatant was saved and the residue was extracted twice with 2 liters 0.5 N acetic acid containing 1 ug/ml pepstatin A (Sigma Chemical Co., Deisenhofen, Federal Republic ofGermany) for 4 h at 20°C. The acid extracts were dialyzed against 50 mM Tris, 2 mM NEM, pH 7.6, and added to the supernatant of the collagenase digest. From the combined supernatants and extracts, type IV collagenous fragments were precipitated by the addition ofsolid NaCl to a final concentration of 2.2 N. The precipitate was dissolved in and dialyzed against 50 mM Tris, 2 M urea, pH 7.6, at 4°C and subjected to a DEAE-cellulose batch procedure. Type IV collagenous fragments were not bound and, after dialysis against 40 mM Tris, 2 mM NEM, 0.5 N NaCI, 5 mM CaC12, pH 7.6, were digested with 5 mg of purified bacterial collagenase (Worthington Biochemical Corp., Freehold, NJ, C1SPA) per kilogram ofstarting material for 6 h at 37°C. After extensive dialysis against 10 mM NH4HCO3, pH 7.9, the material was lyophilized and applied to a column (3.5 x 130 cm) of agarose A 1. (26) from citrated plasma. Pepsin digestion of placenta was carried out as described in the literature in order to obtain laminin fragment Pi (20, 27) , type IV collagenous fragments (27), 7-S collagen (14, 27) , collagen type V (form AB2, 27), and type VI collagen (28).
Analytical methods. Proteins were characterized by sodium dodecyl sulfate (SDS)-polyacrylamide slab gel electrophoresis prior to and after reduction with 5% mercaptoethanol (29) . For amino acid analysis (D-500 analyzer, Durrum Corp., Palo Alto, CA), samples were hydrolyzed with 6 N HCI in the presence of 0.05% mercaptoethanol under N2 for 20 h at 1 10°C. Values for threonine and serine were corrected for losses during hydrolysis by factors 1.08 and 1.21, respectively. Cysteine was determined after reduction and aminoethylation of the protein.
Electron microscopy. The globular domain used in this investigation was studied by the rotary shadowing technique modified for connective tissue proteins (30 Antisera. To produce antisera against NCI, 0.3 mg of the antigen (subfraction b, see Results) was dissolved in 0.5 ml of0.05 M NH4HC03, pH 7.8, mixed with 0.5 ml complete Freund's adjuvant (Difco Laboratories, Detroit, MI) and injected subcutaneously into New Zealand White rabbits. The same amount of antigen mixed with incomplete adjuvant was given twice in 3-wk intervals. 2 wk after the last booster injection, the animals were killed by heart puncture. Rabbit antiserum against mouse IgG was obtained by a similar protocol. Goat antiserum against rabbit IgG was produced following a similar schedule using 4 mg of rabbit IgG dissolved in 2 ml phosphate-buffered saline (PBS) and mixed with the same amount ofadjuvant. Blood (200-400 ml) was drawn from the Jugular vein.
Affinity chromatography. For affinity purification (27) , antiserum against NCI was passed over columns of immobilized human laminin P1 fragment, collagens type IV (triple helical and 7-S domains), V, and VI, and finally NCI fragment (fraction b). Briefly, 4-10 mg of protein were coupled to cyanogen bromide (CNBr)-activated Sepharose (Pharmacia) following the procedures supplied by the manufacturer. 4 Radioimmunoassays. NCI fragment was labeled with 1251 using the procedure ofBolton and Hunter (34) . 1251 was linked to other connective tissue proteins (see the above subsection "Other proteins and peptides") by the chloramine-T method (27, 28). Separation ofbound from unbound label was achieved by dialysis against four changes of PBS containing 0.5 N NaCl and 0.04% Tween 20. The percentage ofprotein-bound label as determined by precipitation with 10% trichloroacetic acid in the presence of 5% serum was between 85% and 95%. Incorporated radioactivity ranged between 8,000 and 15,000 cpm/ng protein. Labeled peptide NCI, when chromatographed on a column of Sephacryl S-300 in PBS, 0.04% Tween 20, was eluted shortly before the albumin standard, with an apparent molecular weight of about 80,000 D.
All immunoassays were carried out in radioimmunoassay (RIA) buffer (PBS, pH 7.4, 0.04% Tween 20) at 4°C with duplicate or triplicate tubes as described (27, 28 (Fig. 1) rified antibody reacted only with the dimeric and monomeric doublet bands considered as characteristic for oligomeric NC1 peptide. Contaminating protein present in a crude NCl-containing fraction did not produce a pattern different from that obtained with pure NC1 antigen (Fig. 2 A) . As with protein stain (Fig. 1) weak bands oftri-, tetra-, penta-, and hexameric material were observed before reduction indicating higher orders of covalent cross-linking within the hexameric NCI globule. Antibody reaction with the reduced bands of molecular weights 35, 70 , and 85 kD was less pronounced, possibly due to their higher degree of unfolding and a higher affinity of the antibody for the native conformation. Furthermore, a monoclonal NCI antibody (IgG2b) could be produced, which revealed a superimposable staining pattern on Western blotting with a lower affinity for penta/hexamers and reduced bands of NCI (Fig. 2 B) , thus demonstrating the purity of the antigen and the specificity of the polyclonal antiserum and antibody. The monoclonal antibody, however, precipitated only 40% of radiolabeled NC1 and could not be used for a sensitive radioimmunoassay (Fig. 3) . When the antiserum, the purified polyclonal or the monoclonal antibodies were applied to cryostat sections of human skin or liver for indirect immunofluorescence, a sharp delineation of subepithelial and vascular basement membranes without any stromal reaction was observed (data not shown).
Radioimmunoassay. For the determination of NCI antigen in biological fluids, we developed an assay based on a rabbit antiserum to fragment NCI and '25I-labeled peptide. Radioactive label was incorporated with the Bolton-Hunter reagent, because iodination by the use of chloramine-T seemed to destroy most of the antigenic determinants. Binding of labeled peptide to excess antibody was 80% and, with a sharp decline, reached 50% at antiserum dilutions of 1:20,000 to 1:50,000 (Fig. 3) . Binding of 1251I-labeled collagens type I, III, V, and VI, 7-S collagen, and the aminoterminal propeptide of type III collagen to the antiserum was completely absent. Only negligible binding was observed with fibronectin and laminin P1 fragment. In that immunoassay results obtained with the purified polyclonal antibody were identical to those with the antiserum, the latter was used in the inhibition assay. Binding of '251-NCI to antibodies could be inhibited by unlabeled peptide showing a linear relationship ranging from 20% to 75% when plotted against the logarithm of inhibitor concentration. Standard antigen, kept in neutral buffer, yielded a highly reproducible 50% inhibition at a concentration of4.4±0.2 ng/ml (mean±SD) in 10 experiments. With monomeric NCI (fraction c, Fig. 1 ) as inhibitor, an 10-fold higher concentration was necessary (Fig. 4 A) . Several human body fluids could act as inhibitors ofthe reaction between labeled NCI and the antiserum. Serial dilutions of 150 sera tested so far showed a slope completely parallel to the standard curve; samples ofurine, however, were slightly less parallel (Fig. 4 B) . Parallelity was also observed for supernatants of fibroblast cell cultures from human liver, whereas bile and ascites caused inhibition slopes intermediate between those of urine and those of serum.
NCI antigen levels in serum and other bodyfluids. NCI was measured in the sera of 30 adult healthy volunteers and found to be 6±2.9 ng/ml (mean±2.5 SD). In patients with fibrotic liver disease, however, we observed a dramatic increase ofthe antigen up to 240 ng/ml (Table II) , correlating to some degree with the severity of the illness. Preliminary data (1 1 sera) showed that in systemic diseases like lupus erythematosus and metastasizing cancers, serum antigen was only slightly elevated (8-18 ng/ml). As mentioned before, inhibition was also detected in other body fluids (Table II) , suggesting a considerable turnover ofNCI and/ or fragments thereof.
Course of serum antigen levels in fibrotic liver disease. In order to obtain a first idea about the diagnostic and prognostic significance of changing serum NCI levels, we observed, over a period of 5-8 mo, two patients with initially severe alcoholic hepatitis (see Methods). One patient (Fig. 5 A) , who during several weeks of hospitalization rapidly recovered, demonstrated a slowly falling albeit elevated level of NCI antigen in serum. The other patient (Fig. 5 B) exhibited extremely high and fluctuating serum NCI with a sharp increase shortly before death. The amino-terminal procollagen type III peptide, now being widely recognized as a serum marker to assess fibrogenic activity in liver disease (35, 36) and measured concomitantly in both patients, took a different somewhat contrapuntal course ( Fig. 5 A and B)'and did not correlate to NCI antigen levels.
Reproducibility andprecision ofthe assay. For 10 successive inhibition assays, the interassay coefficients of variation for the standard 50% intercept as well as the normal and the pathological control serum were below 5.8% (Table III A) . The intraassay variation was tested with the two control sera and found to be less than 4.7% (Table III B) . When standard antigen was added to normal serum and bile in three different quantities to give a concentration of 55, 220, and 1,100 ng/ml serum or bile, 95-105% recovery by RIA measurement was observed in three different experiments. This indicates that apparently no serum or bile components interact with the globular domain to interfere with antibody binding. Molecular weight of serum NCI antigen. 2-4 ml serum of patients with alcoholic hepatitis containing 50-105 ng/ml of cross-reacting antigen was subjected to molecular sieve chromatography on a column of agarose A 5 M. Fractions of three individual runs were assayed by RIA for NCI, and a representative run is shown in Fig. 6 . One major peak ofinhibiting activity representing 67% oftotal serum antigen recovered from the column appeared at the position ofa serum albumin standard with a molecular weight of -60 kD (Fig. 6 ). This elution position was slightly below that for the labeled peptide NCl used in this RIA, which consisted predominantly of di-trimeric units with a molecular weight of -80 kD. Two smaller peaks representing 9% and 14% of total NC1 were observed at the position of the IgG marker, possibly because of the presence of the hexameric and trimeric globular domain (molecular weights 170 and 80 kD, respectively), and only 10% of serum NC1 activity eluted in fractions close to the excluded volume of the column with a molecular weight > 700 kD. These four peaks represented 95% of cross-reacting serum antigen applied to the column as measured by NCI RIA.
Discussion
We isolated the carboxy-terminal cross-linking domain (NCI) of type IV procollagen from human placenta and used it for the 10~~~~~~~~~~~~~t-ng/ml (2.5 SD) well above the safe detection limit (3 ng/ml) of the assay. When serum of patients with alcoholic hepatitis was subjected to molecular sieve chromatography, -70% of the antigenic material eluted with an apparent molecular weight of 50-60 kD equivalent to the dimeric fragment isolated by collagenase digestion from human placenta. Together with -20% of the antigen, which presumably represents the hexameric and trimeric globular domain (molecular weights of 170 and 80 kD, respectively), this finding shows that -90% of circulating NCI antigen have completely lost the long collagenous arms extending towards the amino-terminal 7-S domain. Thus we conclude that serum NCI is a result of and predominantly reflects degradation of basement membrane collagen. The remaining 10% of serum antigen had a molecular weight > 700 kD as compared with collagenous standards. Previously, type IV procollagen from cell culture media could be visualized by electron microscopy as a triple-stranded molecule of 395 nm in length containing NCI as the trimeric carboxy-terminal globular domain (37). It was then shown by Duncan et al. (15) that the formation of the network of basement membrane collagen is initiated by the condensation of four type IV procollagen moieties at the aminotermini to the tetrameric 7-S domain. In contrast with these findings, Yurchenco et al. (38) reported that dimerization of procollagen IV at the carboxytermini (NCI domain) precedes its amino-terminal association to the 7-S domain. According to the latter report, the fraction with high molecular weight could consist of dimeric (1,100 kD) procollagen type IV, which, as a marker of biosynthesis, has escaped its integration into the extracellular matrix. Another interpretation is favored by an investigation of Fessler et al. (39) , localizing the cleavage point ofa purified murine tumor type IV collagenase at a distance 265 nm away from the carboxyterminus of procollagen IV. The primary cleavage product of the matrix type IV collagen containing the NCI globule should then have a molecular weight of 2 X 360 kD, also being consistent with a molecular weight > 700 kD. A definite answer to the question whether the high molecular weight fraction represents biosynthesis or degradation of basement membrane collagen can only be given by its isolation and electron-microscopic visualization.
It has been shown by immunofluorescence that interstitial and basement membrane proteins are intrinsic structures of the normal liver and are excessively deposited in the extracellular space even in early stages of hepatic fibrosis, probably owing to the activation of myofibroblasts (5) . Although the deposition of collagen type III and collagen type IV might follow different kinetics, our own data show that their total tissue content correlates closely in early and advanced stages of hepatic fibrosis (40) . As a serum marker, PIIIP is now generally considered as being indicative of connective tissue biosynthesis in hepatic fibrogenesis (36) . In Fig. 5 , we presented diagrams showing the course of serum PIIIP and serum NCI over several months in two patients with severe alcoholic liver disease. From these diagrams, it is evident that only little and an often inverse correlation exists between PIIIP and NCI serum levels in these patients. In the light of PIIIP as a marker of synthesis and NCI as a marker of degradation of the extracellular matrix, an increase in the ratio of NCI to PIIIP could indicate an overall removal of fibrotic liver tissue, whereas a decrease of that ratio could herald enhanced deposition of fibrous tissue in the liver. It is further remarkable that patient A in Fig. 5 , who disclosed elevated but relatively constant and finally declining serum levels of both NCI and PIIIP, entered a stage of clinical stability in spite of the development of cirrhosis. Patient B, however, with highly elevated and fluctuating values died from hepatic failure.
NCI was also detected in bile, where its level rose up to 10 times above normal (4.9±1.4 ng/ml; mean±+l SD) in cases of biliary inflammation and/or obstruction. It remains to be established whether biliary NC is primarily derived from the basement membrane underlying the biliary epithelium. Ascitic fluid contained very high levels of NCI, but no correlation with the concentration in serum, which was taken at the same time, could be observed. Appreciable amounts of antigen occurred in urine with a slope of inhibition slightly less parallel to the standard than that of serum. Whether the urinary and part of the biliary NCI peptides are more degraded products and similar to the less immunoreactive monomeric form of the antigen awaits further clarification. The use of Fab antibody fragments for RIA may help to measure smaller forms of NCI. An analogous approach has been successfully applied for the aminoterminal procollagen type III peptide (41) .
Inasmuch as we expected serum NCI not only to be elevated in fibrogenic liver disease but also in conditions in which an increased turnover of basement membranes might be involved, we measured a collection of sera obtained from patients with autoimmune diseases (scleroderma, lupus erythematosus disseminatus) and liver metastasis ofcolonic adenocarcinoma. NC1 was moderately elevated (1.5-3 times above normal) in most of these sera, but was normal in nonmetastatic colon carcinoma. Prospectively designed clinical studies are now feasible to validate the diagnostic and prognostic value of our NCl RIA. Its wide application should shed further light on the physiology and pathophysiology of type IV collagen metabolism in the human organism.
